Global Opioid Receptor Agonist Market Growth 2022-2028
- LP 4947593
- 119 Pages
- April 2022
- Pharmaceuticals
The United States Opioid Receptor Agonist market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Opioid Receptor Agonist market, reaching US$ million by the year 2028. As for the Europe Opioid Receptor Agonist landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Opioid Receptor Agonist players cover Teva Pharmaceutical Industries, Johnson & Johnson, Pfizer, and Fresenius Kabi, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Opioid Receptor Agonist market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Fentanyl
Codeine
Morphine
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Teva Pharmaceutical Industries
Johnson & Johnson
Pfizer
Fresenius Kabi
Mylan N.V.
Allergan
US WorldMeds
Piramal Critical Care
DAIICHI SANKYO COMPANY
Purdue Pharma
Hikma Pharmaceuticals
Endo Pharmaceuticals
Sun Pharmaceutical Industries
Tris Pharma
Indivior
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Opioid Receptor Agonist Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Opioid Receptor Agonist by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Opioid Receptor Agonist by Country/Region, 2017, 2022 & 2028
2.2 Opioid Receptor Agonist Segment by Type
2.2.1 Fentanyl
2.2.2 Codeine
2.2.3 Morphine
2.2.4 Others
2.3 Opioid Receptor Agonist Sales by Type
2.3.1 Global Opioid Receptor Agonist Sales Market Share by Type (2017-2022)
2.3.2 Global Opioid Receptor Agonist Revenue and Market Share by Type (2017-2022)
2.3.3 Global Opioid Receptor Agonist Sale Price by Type (2017-2022)
2.4 Opioid Receptor Agonist Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Online Pharmacy
2.4.3 Retail Pharmacy
2.5 Opioid Receptor Agonist Sales by Application
2.5.1 Global Opioid Receptor Agonist Sale Market Share by Application (2017-2022)
2.5.2 Global Opioid Receptor Agonist Revenue and Market Share by Application (2017-2022)
2.5.3 Global Opioid Receptor Agonist Sale Price by Application (2017-2022)
3 Global Opioid Receptor Agonist by Company
3.1 Global Opioid Receptor Agonist Breakdown Data by Company
3.1.1 Global Opioid Receptor Agonist Annual Sales by Company (2020-2022)
3.1.2 Global Opioid Receptor Agonist Sales Market Share by Company (2020-2022)
3.2 Global Opioid Receptor Agonist Annual Revenue by Company (2020-2022)
3.2.1 Global Opioid Receptor Agonist Revenue by Company (2020-2022)
3.2.2 Global Opioid Receptor Agonist Revenue Market Share by Company (2020-2022)
3.3 Global Opioid Receptor Agonist Sale Price by Company
3.4 Key Manufacturers Opioid Receptor Agonist Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioid Receptor Agonist Product Location Distribution
3.4.2 Players Opioid Receptor Agonist Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Opioid Receptor Agonist by Geographic Region
4.1 World Historic Opioid Receptor Agonist Market Size by Geographic Region (2017-2022)
4.1.1 Global Opioid Receptor Agonist Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Opioid Receptor Agonist Annual Revenue by Geographic Region
4.2 World Historic Opioid Receptor Agonist Market Size by Country/Region (2017-2022)
4.2.1 Global Opioid Receptor Agonist Annual Sales by Country/Region (2017-2022)
4.2.2 Global Opioid Receptor Agonist Annual Revenue by Country/Region
4.3 Americas Opioid Receptor Agonist Sales Growth
4.4 APAC Opioid Receptor Agonist Sales Growth
4.5 Europe Opioid Receptor Agonist Sales Growth
4.6 Middle East & Africa Opioid Receptor Agonist Sales Growth
5 Americas
5.1 Americas Opioid Receptor Agonist Sales by Country
5.1.1 Americas Opioid Receptor Agonist Sales by Country (2017-2022)
5.1.2 Americas Opioid Receptor Agonist Revenue by Country (2017-2022)
5.2 Americas Opioid Receptor Agonist Sales by Type
5.3 Americas Opioid Receptor Agonist Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioid Receptor Agonist Sales by Region
6.1.1 APAC Opioid Receptor Agonist Sales by Region (2017-2022)
6.1.2 APAC Opioid Receptor Agonist Revenue by Region (2017-2022)
6.2 APAC Opioid Receptor Agonist Sales by Type
6.3 APAC Opioid Receptor Agonist Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Opioid Receptor Agonist by Country
7.1.1 Europe Opioid Receptor Agonist Sales by Country (2017-2022)
7.1.2 Europe Opioid Receptor Agonist Revenue by Country (2017-2022)
7.2 Europe Opioid Receptor Agonist Sales by Type
7.3 Europe Opioid Receptor Agonist Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Opioid Receptor Agonist by Country
8.1.1 Middle East & Africa Opioid Receptor Agonist Sales by Country (2017-2022)
8.1.2 Middle East & Africa Opioid Receptor Agonist Revenue by Country (2017-2022)
8.2 Middle East & Africa Opioid Receptor Agonist Sales by Type
8.3 Middle East & Africa Opioid Receptor Agonist Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Opioid Receptor Agonist
10.3 Manufacturing Process Analysis of Opioid Receptor Agonist
10.4 Industry Chain Structure of Opioid Receptor Agonist
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Opioid Receptor Agonist Distributors
11.3 Opioid Receptor Agonist Customer
12 World Forecast Review for Opioid Receptor Agonist by Geographic Region
12.1 Global Opioid Receptor Agonist Market Size Forecast by Region
12.1.1 Global Opioid Receptor Agonist Forecast by Region (2023-2028)
12.1.2 Global Opioid Receptor Agonist Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Opioid Receptor Agonist Forecast by Type
12.7 Global Opioid Receptor Agonist Forecast by Application
13 Key Players Analysis
13.1 Teva Pharmaceutical Industries
13.1.1 Teva Pharmaceutical Industries Company Information
13.1.2 Teva Pharmaceutical Industries Opioid Receptor Agonist Product Offered
13.1.3 Teva Pharmaceutical Industries Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Teva Pharmaceutical Industries Main Business Overview
13.1.5 Teva Pharmaceutical Industries Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson Opioid Receptor Agonist Product Offered
13.2.3 Johnson & Johnson Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Opioid Receptor Agonist Product Offered
13.3.3 Pfizer Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Fresenius Kabi
13.4.1 Fresenius Kabi Company Information
13.4.2 Fresenius Kabi Opioid Receptor Agonist Product Offered
13.4.3 Fresenius Kabi Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Fresenius Kabi Main Business Overview
13.4.5 Fresenius Kabi Latest Developments
13.5 Mylan N.V.
13.5.1 Mylan N.V. Company Information
13.5.2 Mylan N.V. Opioid Receptor Agonist Product Offered
13.5.3 Mylan N.V. Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Mylan N.V. Main Business Overview
13.5.5 Mylan N.V. Latest Developments
13.6 Allergan
13.6.1 Allergan Company Information
13.6.2 Allergan Opioid Receptor Agonist Product Offered
13.6.3 Allergan Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Allergan Main Business Overview
13.6.5 Allergan Latest Developments
13.7 US WorldMeds
13.7.1 US WorldMeds Company Information
13.7.2 US WorldMeds Opioid Receptor Agonist Product Offered
13.7.3 US WorldMeds Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 US WorldMeds Main Business Overview
13.7.5 US WorldMeds Latest Developments
13.8 Piramal Critical Care
13.8.1 Piramal Critical Care Company Information
13.8.2 Piramal Critical Care Opioid Receptor Agonist Product Offered
13.8.3 Piramal Critical Care Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Piramal Critical Care Main Business Overview
13.8.5 Piramal Critical Care Latest Developments
13.9 DAIICHI SANKYO COMPANY
13.9.1 DAIICHI SANKYO COMPANY Company Information
13.9.2 DAIICHI SANKYO COMPANY Opioid Receptor Agonist Product Offered
13.9.3 DAIICHI SANKYO COMPANY Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 DAIICHI SANKYO COMPANY Main Business Overview
13.9.5 DAIICHI SANKYO COMPANY Latest Developments
13.10 Purdue Pharma
13.10.1 Purdue Pharma Company Information
13.10.2 Purdue Pharma Opioid Receptor Agonist Product Offered
13.10.3 Purdue Pharma Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Purdue Pharma Main Business Overview
13.10.5 Purdue Pharma Latest Developments
13.11 Hikma Pharmaceuticals
13.11.1 Hikma Pharmaceuticals Company Information
13.11.2 Hikma Pharmaceuticals Opioid Receptor Agonist Product Offered
13.11.3 Hikma Pharmaceuticals Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Hikma Pharmaceuticals Main Business Overview
13.11.5 Hikma Pharmaceuticals Latest Developments
13.12 Endo Pharmaceuticals
13.12.1 Endo Pharmaceuticals Company Information
13.12.2 Endo Pharmaceuticals Opioid Receptor Agonist Product Offered
13.12.3 Endo Pharmaceuticals Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Endo Pharmaceuticals Main Business Overview
13.12.5 Endo Pharmaceuticals Latest Developments
13.13 Sun Pharmaceutical Industries
13.13.1 Sun Pharmaceutical Industries Company Information
13.13.2 Sun Pharmaceutical Industries Opioid Receptor Agonist Product Offered
13.13.3 Sun Pharmaceutical Industries Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Sun Pharmaceutical Industries Main Business Overview
13.13.5 Sun Pharmaceutical Industries Latest Developments
13.14 Tris Pharma
13.14.1 Tris Pharma Company Information
13.14.2 Tris Pharma Opioid Receptor Agonist Product Offered
13.14.3 Tris Pharma Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Tris Pharma Main Business Overview
13.14.5 Tris Pharma Latest Developments
13.15 Indivior
13.15.1 Indivior Company Information
13.15.2 Indivior Opioid Receptor Agonist Product Offered
13.15.3 Indivior Opioid Receptor Agonist Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Indivior Main Business Overview
13.15.5 Indivior Latest Developments
14 Research Findings and Conclusion
Table 1. Opioid Receptor Agonist Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Opioid Receptor Agonist Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Fentanyl
Table 4. Major Players of Codeine
Table 5. Major Players of Morphine
Table 6. Major Players of Others
Table 7. Global Opioid Receptor Agonist Sales by Type (2017-2022) & (K Units)
Table 8. Global Opioid Receptor Agonist Sales Market Share by Type (2017-2022)
Table 9. Global Opioid Receptor Agonist Revenue by Type (2017-2022) & ($ million)
Table 10. Global Opioid Receptor Agonist Revenue Market Share by Type (2017-2022)
Table 11. Global Opioid Receptor Agonist Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Opioid Receptor Agonist Sales by Application (2017-2022) & (K Units)
Table 13. Global Opioid Receptor Agonist Sales Market Share by Application (2017-2022)
Table 14. Global Opioid Receptor Agonist Revenue by Application (2017-2022)
Table 15. Global Opioid Receptor Agonist Revenue Market Share by Application (2017-2022)
Table 16. Global Opioid Receptor Agonist Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Opioid Receptor Agonist Sales by Company (2020-2022) & (K Units)
Table 18. Global Opioid Receptor Agonist Sales Market Share by Company (2020-2022)
Table 19. Global Opioid Receptor Agonist Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Opioid Receptor Agonist Revenue Market Share by Company (2020-2022)
Table 21. Global Opioid Receptor Agonist Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Opioid Receptor Agonist Producing Area Distribution and Sales Area
Table 23. Players Opioid Receptor Agonist Products Offered
Table 24. Opioid Receptor Agonist Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Opioid Receptor Agonist Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Opioid Receptor Agonist Sales Market Share Geographic Region (2017-2022)
Table 29. Global Opioid Receptor Agonist Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Opioid Receptor Agonist Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Opioid Receptor Agonist Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Opioid Receptor Agonist Sales Market Share by Country/Region (2017-2022)
Table 33. Global Opioid Receptor Agonist Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Opioid Receptor Agonist Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Opioid Receptor Agonist Sales by Country (2017-2022) & (K Units)
Table 36. Americas Opioid Receptor Agonist Sales Market Share by Country (2017-2022)
Table 37. Americas Opioid Receptor Agonist Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Opioid Receptor Agonist Revenue Market Share by Country (2017-2022)
Table 39. Americas Opioid Receptor Agonist Sales by Type (2017-2022) & (K Units)
Table 40. Americas Opioid Receptor Agonist Sales Market Share by Type (2017-2022)
Table 41. Americas Opioid Receptor Agonist Sales by Application (2017-2022) & (K Units)
Table 42. Americas Opioid Receptor Agonist Sales Market Share by Application (2017-2022)
Table 43. APAC Opioid Receptor Agonist Sales by Region (2017-2022) & (K Units)
Table 44. APAC Opioid Receptor Agonist Sales Market Share by Region (2017-2022)
Table 45. APAC Opioid Receptor Agonist Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Opioid Receptor Agonist Revenue Market Share by Region (2017-2022)
Table 47. APAC Opioid Receptor Agonist Sales by Type (2017-2022) & (K Units)
Table 48. APAC Opioid Receptor Agonist Sales Market Share by Type (2017-2022)
Table 49. APAC Opioid Receptor Agonist Sales by Application (2017-2022) & (K Units)
Table 50. APAC Opioid Receptor Agonist Sales Market Share by Application (2017-2022)
Table 51. Europe Opioid Receptor Agonist Sales by Country (2017-2022) & (K Units)
Table 52. Europe Opioid Receptor Agonist Sales Market Share by Country (2017-2022)
Table 53. Europe Opioid Receptor Agonist Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Opioid Receptor Agonist Revenue Market Share by Country (2017-2022)
Table 55. Europe Opioid Receptor Agonist Sales by Type (2017-2022) & (K Units)
Table 56. Europe Opioid Receptor Agonist Sales Market Share by Type (2017-2022)
Table 57. Europe Opioid Receptor Agonist Sales by Application (2017-2022) & (K Units)
Table 58. Europe Opioid Receptor Agonist Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Opioid Receptor Agonist Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Opioid Receptor Agonist Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Opioid Receptor Agonist Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Opioid Receptor Agonist Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Opioid Receptor Agonist Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Opioid Receptor Agonist Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Opioid Receptor Agonist Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Opioid Receptor Agonist Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Opioid Receptor Agonist
Table 68. Key Market Challenges & Risks of Opioid Receptor Agonist
Table 69. Key Industry Trends of Opioid Receptor Agonist
Table 70. Opioid Receptor Agonist Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Opioid Receptor Agonist Distributors List
Table 73. Opioid Receptor Agonist Customer List
Table 74. Global Opioid Receptor Agonist Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Opioid Receptor Agonist Sales Market Forecast by Region
Table 76. Global Opioid Receptor Agonist Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Opioid Receptor Agonist Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Opioid Receptor Agonist Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Opioid Receptor Agonist Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Opioid Receptor Agonist Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Opioid Receptor Agonist Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Opioid Receptor Agonist Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Opioid Receptor Agonist Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Opioid Receptor Agonist Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Opioid Receptor Agonist Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Opioid Receptor Agonist Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Opioid Receptor Agonist Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Opioid Receptor Agonist Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Opioid Receptor Agonist Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Opioid Receptor Agonist Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Opioid Receptor Agonist Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Opioid Receptor Agonist Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Opioid Receptor Agonist Revenue Market Share Forecast by Application (2023-2028)
Table 94. Teva Pharmaceutical Industries Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 95. Teva Pharmaceutical Industries Opioid Receptor Agonist Product Offered
Table 96. Teva Pharmaceutical Industries Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Teva Pharmaceutical Industries Main Business
Table 98. Teva Pharmaceutical Industries Latest Developments
Table 99. Johnson & Johnson Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 100. Johnson & Johnson Opioid Receptor Agonist Product Offered
Table 101. Johnson & Johnson Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Johnson & Johnson Main Business
Table 103. Johnson & Johnson Latest Developments
Table 104. Pfizer Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 105. Pfizer Opioid Receptor Agonist Product Offered
Table 106. Pfizer Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Pfizer Main Business
Table 108. Pfizer Latest Developments
Table 109. Fresenius Kabi Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 110. Fresenius Kabi Opioid Receptor Agonist Product Offered
Table 111. Fresenius Kabi Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Fresenius Kabi Main Business
Table 113. Fresenius Kabi Latest Developments
Table 114. Mylan N.V. Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 115. Mylan N.V. Opioid Receptor Agonist Product Offered
Table 116. Mylan N.V. Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Mylan N.V. Main Business
Table 118. Mylan N.V. Latest Developments
Table 119. Allergan Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 120. Allergan Opioid Receptor Agonist Product Offered
Table 121. Allergan Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Allergan Main Business
Table 123. Allergan Latest Developments
Table 124. US WorldMeds Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 125. US WorldMeds Opioid Receptor Agonist Product Offered
Table 126. US WorldMeds Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. US WorldMeds Main Business
Table 128. US WorldMeds Latest Developments
Table 129. Piramal Critical Care Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 130. Piramal Critical Care Opioid Receptor Agonist Product Offered
Table 131. Piramal Critical Care Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Piramal Critical Care Main Business
Table 133. Piramal Critical Care Latest Developments
Table 134. DAIICHI SANKYO COMPANY Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 135. DAIICHI SANKYO COMPANY Opioid Receptor Agonist Product Offered
Table 136. DAIICHI SANKYO COMPANY Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. DAIICHI SANKYO COMPANY Main Business
Table 138. DAIICHI SANKYO COMPANY Latest Developments
Table 139. Purdue Pharma Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 140. Purdue Pharma Opioid Receptor Agonist Product Offered
Table 141. Purdue Pharma Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Purdue Pharma Main Business
Table 143. Purdue Pharma Latest Developments
Table 144. Hikma Pharmaceuticals Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 145. Hikma Pharmaceuticals Opioid Receptor Agonist Product Offered
Table 146. Hikma Pharmaceuticals Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 147. Hikma Pharmaceuticals Main Business
Table 148. Hikma Pharmaceuticals Latest Developments
Table 149. Endo Pharmaceuticals Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 150. Endo Pharmaceuticals Opioid Receptor Agonist Product Offered
Table 151. Endo Pharmaceuticals Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 152. Endo Pharmaceuticals Main Business
Table 153. Endo Pharmaceuticals Latest Developments
Table 154. Sun Pharmaceutical Industries Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 155. Sun Pharmaceutical Industries Opioid Receptor Agonist Product Offered
Table 156. Sun Pharmaceutical Industries Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 157. Sun Pharmaceutical Industries Main Business
Table 158. Sun Pharmaceutical Industries Latest Developments
Table 159. Tris Pharma Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 160. Tris Pharma Opioid Receptor Agonist Product Offered
Table 161. Tris Pharma Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 162. Tris Pharma Main Business
Table 163. Tris Pharma Latest Developments
Table 164. Indivior Basic Information, Opioid Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 165. Indivior Opioid Receptor Agonist Product Offered
Table 166. Indivior Opioid Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 167. Indivior Main Business
Table 168. Indivior Latest Developments
List of Figures
Figure 1. Picture of Opioid Receptor Agonist
Figure 2. Opioid Receptor Agonist Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioid Receptor Agonist Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Opioid Receptor Agonist Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Opioid Receptor Agonist Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Fentanyl
Figure 10. Product Picture of Codeine
Figure 11. Product Picture of Morphine
Figure 12. Product Picture of Others
Figure 13. Global Opioid Receptor Agonist Sales Market Share by Type in 2021
Figure 14. Global Opioid Receptor Agonist Revenue Market Share by Type (2017-2022)
Figure 15. Opioid Receptor Agonist Consumed in Hospital Pharmacy
Figure 16. Global Opioid Receptor Agonist Market: Hospital Pharmacy (2017-2022) & (K Units)
Figure 17. Opioid Receptor Agonist Consumed in Online Pharmacy
Figure 18. Global Opioid Receptor Agonist Market: Online Pharmacy (2017-2022) & (K Units)
Figure 19. Opioid Receptor Agonist Consumed in Retail Pharmacy
Figure 20. Global Opioid Receptor Agonist Market: Retail Pharmacy (2017-2022) & (K Units)
Figure 21. Global Opioid Receptor Agonist Sales Market Share by Application (2017-2022)
Figure 22. Global Opioid Receptor Agonist Revenue Market Share by Application in 2021
Figure 23. Opioid Receptor Agonist Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Opioid Receptor Agonist Revenue Market Share by Company in 2021
Figure 25. Global Opioid Receptor Agonist Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Opioid Receptor Agonist Revenue Market Share by Geographic Region in 2021
Figure 27. Global Opioid Receptor Agonist Sales Market Share by Region (2017-2022)
Figure 28. Global Opioid Receptor Agonist Revenue Market Share by Country/Region in 2021
Figure 29. Americas Opioid Receptor Agonist Sales 2017-2022 (K Units)
Figure 30. Americas Opioid Receptor Agonist Revenue 2017-2022 ($ Millions)
Figure 31. APAC Opioid Receptor Agonist Sales 2017-2022 (K Units)
Figure 32. APAC Opioid Receptor Agonist Revenue 2017-2022 ($ Millions)
Figure 33. Europe Opioid Receptor Agonist Sales 2017-2022 (K Units)
Figure 34. Europe Opioid Receptor Agonist Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Opioid Receptor Agonist Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Opioid Receptor Agonist Revenue 2017-2022 ($ Millions)
Figure 37. Americas Opioid Receptor Agonist Sales Market Share by Country in 2021
Figure 38. Americas Opioid Receptor Agonist Revenue Market Share by Country in 2021
Figure 39. United States Opioid Receptor Agonist Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Opioid Receptor Agonist Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Opioid Receptor Agonist Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Opioid Receptor Agonist Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Opioid Receptor Agonist Sales Market Share by Region in 2021
Figure 44. APAC Opioid Receptor Agonist Revenue Market Share by Regions in 2021
Figure 45. China Opioid Receptor Agonist Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Opioid Receptor Agonist Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Opioid Receptor Agonist Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Opioid Receptor Agonist Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Opioid Receptor Agonist Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Opioid Receptor Agonist Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Opioid Receptor Agonist Sales Market Share by Country in 2021
Figure 52. Europe Opioid Receptor Agonist Revenue Market Share by Country in 2021
Figure 53. Germany Opioid Receptor Agonist Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Opioid Receptor Agonist Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Opioid Receptor Agonist Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Opioid Receptor Agonist Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Opioid Receptor Agonist Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Opioid Receptor Agonist Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Opioid Receptor Agonist Revenue Market Share by Country in 2021
Figure 60. Egypt Opioid Receptor Agonist Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Opioid Receptor Agonist Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Opioid Receptor Agonist Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Opioid Receptor Agonist Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Opioid Receptor Agonist Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Opioid Receptor Agonist in 2021
Figure 66. Manufacturing Process Analysis of Opioid Receptor Agonist
Figure 67. Industry Chain Structure of Opioid Receptor Agonist
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
